Serum concentration of asprosin in new-onset type 2 diabetes
Abstract Background Asprosin, a newly identified adipokine, is pathologically increased in individuals with insulin resistance. However, the available evidence on the association of asprosin and type 2 diabetes mellitus (T2DM) status is still scarce. Therefore, this study aimed to determine the rela...
שמור ב:
| Principais autores: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2020-07-01
|
| סדרה: | Diabetology & Metabolic Syndrome |
| נושאים: | |
| גישה מקוונת: | http://link.springer.com/article/10.1186/s13098-020-00564-w |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
